SA ENDOCRINOLOGY LIMITEDActive
Key figures
Like most small UK companies, SA ENDOCRINOLOGY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2021/22–2024/25
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|
| Cash at bank and in hand | 4,327 | 51,327 | 134,066 | 137,529 |
| Total assets | — | — | 138,576 | 153,447 |
| Total liabilities | 3,907 | 13,510 | 23,551 | 7,528 |
| Net assets / total equity | 420 | 37,817 | 115,025 | 145,919 |
| Average number of employees | 2 | 2 | 2 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SA ENDOCRINOLOGY LIMITED
Company
SA ENDOCRINOLOGY LIMITED is a private limited company registered with Companies House under company number 13640152. It was incorporated on 23 Sep 2021. Its status is active. The registered office is in Chatham (ME4). Its nature of business (SIC 2007) is general medical practice activities (86210).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files abridged accounts (unaudited). Net assets were £145,919, up 26.9% on the previous year. Cash at bank and in hand was £137,529. Total assets were £153,447 and total liabilities £7,528. The company had an average of 2 employees. Figures are available for 4 financial years (2021/22–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 9 Aug 2027.